Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate

Epilepsia
M E SmithF Gilliam

Abstract

To contrast the effects of lamotrigine (LTG) and topiramate (TPM) on cognitive task-related and resting-state EEG and evoked potential (EP) measures. We used a double-blind, randomized, crossover design. Healthy adults (N = 29) had two 8-week periods of dose escalation, 4 weeks of drug maintenance (300 mg daily), and 4 weeks of washout. EEG was recorded during working memory (WM) tasks and resting conditions at baseline, at the end of each maintenance phase, and after final washout. RESULTS. LTG did not affect overt performance on the tasks, although it reduced EEG power in both resting and WM task conditions, most prominently in the 6- to 12-Hz frequency range, and attenuated P300 evoked-potential amplitude equally in both WM task loads. TPM slowed responses and increased errors. It also increased EEG power below 6 Hz in all conditions, and reduced the amplitude of a slow wave observed in a difficult version of the WM task. The drugs produced both task-independent and task-related alterations in neurophysiologic measures. The EEG and EP changes produced by TPM are consistent with an impairment of WM, as evidenced by overt performance deficits on the behavioral tasks. By contrast, the reduction in synchronous cortical activity ...Continue Reading

References

Jul 1, 1977·Electroencephalography and Clinical Neurophysiology·A S GevinsC L Yeager
Oct 1, 1992·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·B S Oken, M Salinsky
Oct 1, 1992·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·T W Picton
Aug 1, 1990·Brain : a Journal of Neurology·G HeitE Halgren
Sep 1, 1986·Electroencephalography and Clinical Neurophysiology·D Urbach, H Pratt
Nov 1, 1982·Electroencephalography and Clinical Neurophysiology·J L Blom, M Anneveldt
Jan 1, 1994·Epilepsia·A W Yuen
Apr 1, 1996·Electroencephalography and Clinical Neurophysiology·A GevinsS Whitfield
Mar 4, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·L K McEvoyA Gevins
Apr 26, 2001·Psychophysiology·J YordanovaJ Polich
Jun 26, 2001·Epilepsia·A P Aldenkamp
Dec 26, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alan GevinsLinda K McEvoy
Jun 6, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Steve S ChungKenneth D Laxer
Mar 1, 2003·Epilepsy & Behavior : E&B·K J MeadorJ M Pellock
Jun 26, 2003·Epilepsia·Albert P AldenkampRianne Reijs
Aug 26, 2003·Best Practice & Research. Clinical Haematology·Anna Falanga, Frederick R Rickles
Apr 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xingbao LiMark S George
Jun 23, 2004·Nature Reviews. Neuroscience·Michael A Rogawski, Wolfgang Löscher
Oct 27, 2004·Psychopharmacology·Aaron B IlanAlan Gevins
Jun 1, 2005·International Journal of Clinical Practice·J A Mauri LlerdaJ Salas Puig
Jun 18, 2005·Seizure : the Journal of the British Epilepsy Association·Renzo GuerriniUNKNOWN TOP-INT-51 Investigators' Group
Sep 9, 2005·Acta Neurologica Scandinavica·S ArroyoUNKNOWN EPMN-106/INT-28 Investigators

❮ Previous
Next ❯

Citations

Jan 26, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A RomigiF Placidi
Oct 5, 2010·Epilepsia·Kimford J MeadorDavid W Loring
Mar 1, 2012·International Journal of Clinical Pharmacology and Therapeutics·Michael Bewernitz, Hartmut Derendorf
Mar 22, 2014·Journal of Epilepsy Research·Sung Min KimKi-Young Jung
Nov 21, 2007·The Journal of Head Trauma Rehabilitation·Vivien TangEleanor Rutledge
Dec 14, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Alan GevinsAaron B Ilan
Oct 18, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Jounhong Ryan ChoSeung Bong Hong
Oct 28, 2010·Neurobiology of Disease·Volodymyr Borysovych BogdanovJean Schoenen
Jul 6, 2010·Pharmacology, Biochemistry, and Behavior·Carl L HartRichard W Foltin
Jul 14, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Alan GevinsGordon Abraham
Oct 2, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hulusi Kececi, Selcuk Atakay
Jul 10, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Frank J E Vajda
Jul 10, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Morgan HaldaneSophia Frangou
May 17, 2008·CNS Neuroscience & Therapeutics·Richard P Shank, Bruce E Maryanoff
Jun 15, 2007·The European Journal of Neuroscience·Jon T BrownAndrew D Randall
Apr 21, 2010·Bipolar Disorders·Mani N PavuluriJohn A Sweeney
Nov 22, 2011·Epilepsy Research·J Stretton, P J Thompson
May 1, 2013·Seizure : the Journal of the British Epilepsy Association·Juri-Alexander WittChristoph Helmstaedter
Dec 1, 2012·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Alan GevinsLita Sam-Vargas
Nov 20, 2012·Epilepsy & Behavior : E&B·Juri-Alexander Witt, Christoph Helmstaedter
Oct 11, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Grace Y WangBruce R Russell
Jan 21, 2011·Seizure : the Journal of the British Epilepsy Association·Nidhi Bharal AgarwalKrishna Kishore Sharma
Aug 4, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Ki-Young JungSeung Bong Hong
Aug 16, 2016·Epilepsy & Behavior : E&B·Kimford J MeadorElizabeth Webster
Jun 4, 2015·Journal of Psychopharmacology·Grace Y WangBruce R Russell
Nov 26, 2010·Journal of Psychopharmacology·Alan GevinsCynthia S Chan
Nov 16, 2007·Journal of Geriatric Psychiatry and Neurology·John O Brooks, Jennifer C Hoblyn
Dec 1, 2012·Therapeutic Advances in Drug Safety·Marco Mula
Feb 6, 2020·Neurology·Bruce Hermann, David W Loring
Dec 4, 2020·Epilepsy & Behavior : E&B·Christopher M BarkleySusan E Marino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.